Browsing by Yonsei Author : Cha, Bong Soo

eperson profile image
Name:
Cha, Bong Soo [차봉수]
orcid http://orcid.org/0000-0003-0542-2854
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7007118478)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 396

This table browses all dspace content
Issue DateTitleJournal Title
2023MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitisMETABOLISM-CLINICAL AND EXPERIMENTAL
2023The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005-2021)DIABETES RESEARCH AND CLINICAL PRACTICE
2023β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 8 monthsDIABETES & METABOLISM
2023Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018 JOURNAL OF CLINICAL MEDICINE
2023Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes FRONTIERS IN ENDOCRINOLOGY
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022The effects of the voglibose on non-alcoholic fatty liver disease in mice model SCIENTIFIC REPORTS
2022Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model Endocrinology and Metabolism(대한내분비학회지)
2022Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice BIOMEDICINES
2022Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy FRONTIERS IN ENDOCRINOLOGY
2022Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018 Endocrinology and Metabolism(대한내분비학회지)
2022Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver diseaseHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2022Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes YONSEI MEDICAL JOURNAL
2022Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 FRONTIERS IN IMMUNOLOGY
2022Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2022Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) BMC MEDICINE
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease JAMA NETWORK OPEN
2022Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2022Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million PeopleHYPERTENSION
2021Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes FRONTIERS IN CARDIOVASCULAR MEDICINE
2021Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2021Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway DIABETES & METABOLISM JOURNAL
2021Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2021Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesDIABETES OBESITY & METABOLISM
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2020Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksDIABETES OBESITY & METABOLISM
2020Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression SCIENTIFIC REPORTS
2020Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesDIABETES & METABOLISM
2020Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes MEDICINE
2020Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association DIABETES & METABOLISM JOURNAL
2020Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study CARDIOVASCULAR DIABETOLOGY
2020A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitusJOURNAL OF DIABETES AND ITS COMPLICATIONS
2020SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease NATURE COMMUNICATIONS
2020Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes SCIENTIFIC REPORTS
2020Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2020Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskAMERICAN JOURNAL OF GASTROENTEROLOGY
2020Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis JOURNAL OF CLINICAL MEDICINE
2020Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial JOURNAL OF CLINICAL MEDICINE
2020Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes Journal of Lipid and Atherosclerosis
2020Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study JOURNAL OF CLINICAL MEDICINE
2019Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes MellitusTRANSPLANTATION PROCEEDINGS
2019The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis JOURNAL OF CLINICAL MEDICINE
2019Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis DIABETES THERAPY
2019Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus SCIENTIFIC REPORTS
2019Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trialDIABETES OBESITY & METABOLISM
2019Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea Endocrinology and Metabolism (대한내분비학회지)
2019Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuriaJournal of Diabetes and Its Complications
2019Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitorsCancer Chemotherapy and Pharmacology

Browse

Links